Childen's Hospital Boston
International Visitorsdotted lineRequest Appointmentdotted lineDirections
 advanced search
About Us Find a Specialist Locations Careers Press Room Giving To
Clinical Services For Patients & Families For Health Professionals Research
My Child Has
or find by letter:  A-F  G-L  M-R  S-Z
Stripes Featured Research dotted line Research Areas & Researchers dotted line Multidisciplinary Programs dotted line Clinical Research dotted line About Us dotted line Research Administration Stripes
 Featured Research
  Christopher Walsh discusses autism research in Middle Eastern families
  Donald Ingber on breast cancer therapy
  David Williams on pediatric research
  Bruce Zetter remembers Judah Folkman
  Donald Ingber on magnetic control of cellular signaling
  Christopher Walsh and Bernard Chang on dyslexia
  George Daley on Korean stem cells' true source
  Judah Folkman on angiogenesis
  Bruce Zetter on research at Children's
  George Daley on parthenogenesis
  Pedro del Nido on fixing heart defects
  Museum of Science Living Laboratory
 Email this page
 Printer Friendly
 X
Flower CHIP researchers discuss the power and potential of bioinformatics
Image
(Above) Ken Mandl, PhD, MPH and John Brownstein, PhD
Using powerful computational tools and a variety of databases -- from insurance claims files to pharmacy records to real-time emergency-room data -- Kenneth Mandl, PhD, MPH and John Brownstein, PhD, have made a variety of discoveries, many of them unexpected, and all of them relevant to public health. They and their colleagues in the Children's Hospital Informatics Program (CHIP) have shown, for example, that the grounding of flights after 9/11 delayed the ensuing influenza season by two weeks, suggesting a way of controlling a dangerous flu pandemic, and that preschoolers lead and drive flu epidemics, a finding that has led to a change in immunization practice. Examining drug side effects, they've shown that the increased risk of heart attacks linked to the blockbuster painkiller Vioxx could have been discovered much earlier -- even four years before the drug was pulled from the market. In their quest for more and better public health data, they've dipped into novel information sources, including Google News reports and Internet chatrooms.

Here, Mandl and Brownstein discuss some recent projects and their future plans, comment on the power and limits of bioinformatics and lay forth their goal of taking their technology to the people and capturing even more data -- by putting patients in control of their own health records.

1. What limits do you face getting the data that you need for your research? 1:27/3.9MB

2. How does Children's plan to capture more data from its patients? 2:03/5.6MB

3. What are the benefits of giving patients control over their health records, as Indivo does? 3:31/9.3MB

4. Why is patient control so essential? 1:25/ 3.8MB

5. If there were a massive outbreak, how would biosurveillance pick it up? 2:25/6.5MB

6. How are news reports enhancing your data collection? 2:01/5.5MB

7. Are you suggesting that the news media may influence health trends? 0:38/1.7MB

8. How does pharmacovigilance improve on traditional drug surveillance? 1:47/4.8MB

9. In the case of Vioxx, how did this play out? 1:29/4MB

10. What's next for Health Map? 1:28/4MB

11. You mean the public can actually contribute data to Health Map? 1:11/3.2MB

12. Bioinformatics is a pretty powerful tool. How do you get ideas for projects? 3:47/XMB

13. What other projects are you now working on? 2:53/7.8MB

 X
Contact Us Site Map Privacy Accessibility Give Now en Español